8306 related articles for article (PubMed ID: 15167584)
1. Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice.
Koehl GE; Andrassy J; Guba M; Richter S; Kroemer A; Scherer MN; Steinbauer M; Graeb C; Schlitt HJ; Jauch KW; Geissler EK
Transplantation; 2004 May; 77(9):1319-26. PubMed ID: 15167584
[TBL] [Abstract][Full Text] [Related]
2. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
[TBL] [Abstract][Full Text] [Related]
3. Tanshinol suppresses cardiac allograft rejection in a murine model.
Lu C; Zeng YQ; Liu H; Xie Q; Xu S; Tu K; Dou C; Dai Z
J Heart Lung Transplant; 2017 Feb; 36(2):227-236. PubMed ID: 27574736
[TBL] [Abstract][Full Text] [Related]
4. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
Yuh DD; Morris RE
Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
6. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy.
Luan FL; Hojo M; Maluccio M; Yamaji K; Suthanthiran M
Transplantation; 2002 May; 73(10):1565-72. PubMed ID: 12042641
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin is an effective inhibitor of human renal cancer metastasis.
Luan FL; Ding R; Sharma VK; Chon WJ; Lagman M; Suthanthiran M
Kidney Int; 2003 Mar; 63(3):917-26. PubMed ID: 12631072
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
10. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
Murphy GJ; Bicknell GR; Nicholson ML
Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
[TBL] [Abstract][Full Text] [Related]
11. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
12. Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.
Seeliger H; Guba M; Koehl GE; Doenecke A; Steinbauer M; Bruns CJ; Wagner C; Frank E; Jauch KW; Geissler EK
Clin Cancer Res; 2004 Mar; 10(5):1843-52. PubMed ID: 15014039
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A Inhibits the T-bet-Dependent Antitumor Response of CD8(+) T Cells.
Rovira J; Renner P; Sabet-Baktach M; Eggenhofer E; Koehl GE; Lantow M; Lang SA; Schlitt HJ; Campistol JM; Geissler EK; Kroemer A
Am J Transplant; 2016 Apr; 16(4):1139-47. PubMed ID: 26855194
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
[TBL] [Abstract][Full Text] [Related]
15. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
Tu Y; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells.
Nakamura T; Nakao T; Yoshimura N; Ashihara E
Am J Transplant; 2015 Sep; 15(9):2364-77. PubMed ID: 25943210
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of everolimus and cyclosporine A on intimal alpha-actin-positive cell dynamics of carotid allografts in mice.
Matsumoto Y; Hof A; Baumlin Y; Müller M; Hof RP
Transplantation; 2004 Aug; 78(3):345-51. PubMed ID: 15316361
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of rapamycin and cyclosporine in prevention of acute kidney allograft rejection in the mouse.
Qi S; Xu D; Peng J; Liu D; Chen H
Microsurgery; 1999; 19(7):344-7. PubMed ID: 10586201
[TBL] [Abstract][Full Text] [Related]
19. Transfusion of ethylene carbodiimide-fixed donor splenocytes prolongs survival of vascularized skin allografts.
Ding J; Liu S; Zhang D; Song Y; Ma X; Yi C; Song B; Xiao B; Su Y; Guo S
J Surg Res; 2018 Jan; 221():343-352. PubMed ID: 29229149
[TBL] [Abstract][Full Text] [Related]
20. The effects of rapamycin in murine peripheral nerve isografts and allografts.
Myckatyn TM; Ellis RA; Grand AG; Sen SK; Lowe JB; Hunter DA; Mackinnon SE
Plast Reconstr Surg; 2002 Jun; 109(7):2405-17. PubMed ID: 12045568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
